Description
A PDI inhibitor (Kd = 62 nM); inhibits PDI chaperone activity in an insulin aggregation assay at 75 µM; reduces PC12 cell death induced by the misfolded huntingtin protein mHTTQ103 (EC50 = 500 nM); reduces MSN degeneration in a rat postnatal cortical brain slice model of mHTTQ73-induced Huntington’s disease
Formal name: 2-[[4-(cyclopropylcarbonyl)-1-piperazinyl]methyl]-1,2-benzisothiazol-3(2H)-one
Synonyms:
Molecular weight: 317.4
CAS: 877963-94-5
Purity: ≥90%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors||Research Area|Neuroscience|Neurodegenerative Disorders|Huntington’s Disease